Komori
Kaken Pharmaceutical (4521) · InitiativeRestated

COVID-19 infection control measures and development of a remote-work environment

First written in FY2021-Q1. 5 of 7 entries say "Restated". Latest entry: FY2022.

7entries
3years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021-Q3 – FY20222020: 220202021: 320212022: 22022
Same theme, other companies
Response to COVID-19 and Transformation of Work StylesA theme 795 companies write about · 219 as a headwind · 531 as a tailwind

The whole theme swung hardest in 2026: 2 of 9 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 798 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「We established a COVID-19 Response Headquarters and implemented infection control measures, including a flextime system, staggered working hours, working from home and refraining from commuting when experiencing a fever (generally 37°C or higher).」

    The Response Headquarters, flextime system, staggered working hours, working from home, refraining from commuting, information provision using digital tools and infection control measures during visits continue.
  2. FY2022-Q3RestatedAnnual report

    「We established a COVID-19 Response Headquarters and implemented infection control measures, including a flextime system, staggered working hours, working from home and refraining from commuting when experiencing a fever (generally 37°C or higher). Regarding information provision activities by medical representatives (MRs) and others, we use digital tools and other resources to respond to the needs of healthcare professionals. When visiting medical institutions, we take thorough infection control measures.」

    The Response Headquarters, flextime system, staggered working hours, working from home, information provision using digital tools and infection control measures during visits continue to be implemented.
  3. FY2022-Q2RestatedAnnual report

    「We established a COVID-19 Response Headquarters and implemented infection control measures, including a flextime system, staggered working hours, working from home and refraining from commuting when experiencing a fever (generally 37°C or higher). Regarding information provision activities by medical representatives (MRs) and others, we use digital tools and other resources to respond to the needs of healthcare professionals. When visiting medical institutions, we take thorough infection control measures.」

    The Response Headquarters, flextime system, staggered working hours, working from home, information provision using digital tools and infection control measures during visits continue to be implemented.
  4. FY2021RestatedAnnual report

    「We established a COVID-19 Response Headquarters and implemented infection control measures, including a flextime system, staggered working hours, working from home and refraining from commuting when experiencing a fever (generally 37°C or higher). Regarding information provision activities by medical representatives (MRs) and others, we use digital tools and other resources to respond to the needs of healthcare professionals.」

    The Response Headquarters, flextime system, staggered working hours, working from home, information provision using digital tools and infection control measures during visits continue.
  5. FY2021-Q3RestatedAnnual report

    「We established a COVID-19 Response Headquarters and implemented infection control measures, including a flextime system, staggered working hours, working from home and refraining from commuting when experiencing a fever (generally 37°C or higher). Regarding information provision activities by medical representatives (MRs) and others, we use digital tools and other resources to respond to the needs of healthcare professionals. When visiting medical institutions, we take thorough infection control measures.」

    The Response Headquarters, flextime system, staggered working hours, working from home, use of digital tools and infection control measures during visits continue to be implemented.
  6. FY2021-Q2AdvancedAnnual report

    「Information activities by medical representatives (MRs) and others are being conducted in line with the needs of healthcare professionals, using digital tools and other resources. When visiting medical institutions, we are implementing adequate infection-control measures.」

    As infection control measures, the company used digital tools for the provision of information by MRs and others and implemented infection control measures when visiting medical institutions. Its response has become more specific, shifting from working from home and, in principle, refraining from visits to the use of digital tools and visits accompanied by preventive measures.
  7. FY2021-Q1First statedAnnual report

    「We established a COVID-19 Response Headquarters and, from March, implemented infection control measures for all employees, including staggered working hours, working from home and refraining from commuting when experiencing a fever (generally 37°C or higher). In addition, regarding visits by medical representatives (MRs) and others to medical institutions, we suspended such visits from 2 March to prevent the spread of infection and instituted working from home in principle.」

    The company established a COVID-19 Response Headquarters and implemented staggered working hours, working from home, refraining from commuting and, in principle, refraining from visits to medical institutions. It also announced a policy of promoting work-style reform and higher productivity by developing and expanding a remote-work environment using ICT.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kaken Pharmaceutical's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.